Virtual CLE
Innovation Institutions and COVID-19: Law and Policy
Presented by: Professor Jacob Sherkow, University of Illinois College of Law
August 4, 2022
12 - 1 p.m.
The COVID-19 pandemic has tested U.S. biomedical innovation institutions like no other public health crisis in modern history. These institutions encompass a variety of legal regimes, including intellectual property law, FDA law, insurance reimbursement under programs such as Medicare and Medicare, and government subsidies for research and development of new biomedical products. While these institutions' response to the pandemic has, with hindsight, largely been successful, the distribution of their goods has been radically uneven. In particular, these institutions' response to COVID-19 has been marked by racial disparities in equity, access, and design. This CLE will walk through some of the legal mechanics of the pandemic; the innovation regimes involved in developing diagnostics, therapeutics, and vaccines to combat COVID-19; and some of the racial disparities present in these medicaments' creation and distribution.
Jacob S. Sherkow is Professor of Law at the College of Law, Professor of Medicine at the Carle Illinois College of Medicine, and Affiliate of the Carl R. Woese Institute for Genomic Biology at the University of Illinois. Professor Sherkow’s research focuses on the legal and ethical implications of advanced biotechnologies, especially as related to intellectual property. He is a leading expert on IP protection for genome-editing technologies, including CRISPR. He is the author of over 60 articles published in both scientific journals and traditional law reviews, including Science, Nature, the Yale Law Journal, and the Stanford Law Review. Since 2018, Sherkow has also been a Permanent Visiting Professor at the Center for Advanced Studies in Biomedical Innovation Law (“CeBIL”) at the University of Copenhagen Faculty of Law. Sherkow’s work has been recognized by both the scientific and legal communities. In 2018, he was appointed to the National Academy of Medicine as an Emerging Leader in Health and Medicine Scholar, and just completed service as an Academic Advisor to the Academies’ Committee on Emerging Science, Technology, and Innovation. Sherkow graduated cum laude from the University of Michigan Law School, where he was an editor of the Michigan Law Review. He holds an M.A. in biotechnology from Columbia University and a B.Sc. from McGill University. In addition to his legal training, Sherkow has several years of experience as a research scientist in molecular biology.
This course is approved for 1.00 Illinois MCLE general credit hours, PR/Diversity & Inclusion credit is pending approval.
This event is free and open to the public, but registration in requested. Please register here:
https://forms.illinois.edu/sec/963347964
Join by Zoom:
https://illinois.zoom.us/j/88356915711?pwd=gn22nu_BNGvu9TCk-sNl54n3XNBEdo.1
Meeting ID: 883 5691 5711
Password: 382851